sleep / English

add

(MedPage Today) -- ORLANDO -- Tirzepatide (Zepbound) improved symptoms of moderate-to-severe obstructive sleep apnea (OSA) in people with obesity, regardless of positive airway pressure (PAP) use, the phase III SURMOUNT OSA trials found.

Drugmaker Eli Lilly is hoping tirzepatide, sold as Mounjaro and Zepbound for diabetes and weight loss, will become the first drug approved to treat sleep apnea, which it says affects some 80 million Americans, many of whom go undiagnosed…

An international study shows new drug improves sleep, health in patients diagnosed with obesity and sleep apnea.

The weight loss drug tirzepatide, the medication in Zepbound and Mounjaro, may help treat severe sleep apnea, a new study finds.

New research finds that the GLP-1 drug tirzepatide may help lessen sleep apnea symptoms. Jackyenjoyphotography/Getty Images

Business Insider's reporter spent 30 hours on an Amtrak train from New York City to Miami, and she said the journey was too long and too bumpy.

A popular obesity drug may help treat a dangerous disorder in which people struggle to breathe while they sleep, a new study finds.

A popular obesity drug may help treat a dangerous disorder in which people struggle to breathe while they sleep, a…

A new study finds the popular obesity drug Zepbound may help treat sleep apnea, a dangerous disorder in which people struggle to breathe during sleep

A new study finds the popular obesity drug Zepbound may help treat sleep apnea, a dangerous disorder in which people struggle to breathe during sleep.

A new study finds the popular obesity drug Zepbound may help treat sleep apnea, a dangerous disorder in which people struggle to breathe during sleep.

A new study finds the popular obesity drug Zepbound may help treat sleep apnea, a dangerous disorder in which people struggle to breathe during sleep.

A new study finds the popular obesity drug Zepbound may help treat sleep apnea, a dangerous disorder in which people struggle to breathe during sleep.

By JONEL ALECCIA AP Health Writer A new study finds the popular obesity drug Zepbound may help treat sleep apnea, a dangerous disorder in which people struggle to breathe during sleep. The research found that people who took tirzepatide…

A new study finds the popular obesity drug Zepbound may help treat sleep apnea, a dangerous disorder in which people struggle to breathe during sleep.

Researchers at University of California San Diego School of Medicine and international collaborators have led a worldwide, advanced study demonstrating the potential of tirzepatide, known to manage type 2 diabetes, as the first effective…

Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing disorder and expects regulators to make a decision as early as the end of the year.